Vaccines for cervical cancer prevention will be available in large quantities from 2024, says SII CEO Adar Poonawalla
25 Jan 2023
Chief Executive Officer of Serum Institute of India (SII), Adar Poonawalla on Wednesday said that the first made-in-India Human Papillomavirus (HPV) "CERVAVAC" vaccine availability will be little in number this year and will be increased in 2024. Talking to the media SII CEO said, "I had come to brief the...
Read More